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Abstract
Recently, a peak at 1.28 ppm in proton magnetic resonance spectroscopy (1H-MRS) of neural stem cells (NSCs)
was introduced as a noninterventional biomarker for neurogenesis in vivo. This would be an urgently needed
requisite for translational studies in humans regarding the beneficial role of adult neurogenesis for the structural
and functional integrity of the brain. However, many concerns have risen about the validity of the proposed
signal as a specific marker for NSCs. The peak has also been related to cell-type-independent phenomena such as
apoptosis or necrosis. Thus, we compared the 1.28-ppm peak in various immature stem cell populations,
including embryonic stem cells, mouse embryonic fibroblasts, embryonic stem cell– and induced pluripotent
stem cell–derived NSCs, ex vivo isolated embryonic NSCs, as well as mature and tumor cell types from different
germ layers. To correlate the integral peak intensity with cell death, we induced both apoptosis with camp-
tothecin and necrosis with sodium azide. A peak at 1.28 ppm was found in most cell types, and in most, but not
all, NSCH cultures, demonstrating no specificity for NSCs. The intensities of the 1.28-ppm resonance signifi-
cantly correlated with the rate of apoptosis, but not with the rate of necrosis, cell cycle phase distribution, cell
size, or type. Multiple regression analysis displayed a significant predictive value of the peak intensity for
apoptosis only. In this context, its specificity for apoptosis as a major selection process during neurogenesis may
suggest this resonance as an indirect marker for neurogenesis in vivo.
Introduction
Animal research provides evidence for both the im-portance of adult neurogenesis for the structural integ-
rity and performance of the central nervous system and at
the same time for the responsiveness of neural stem cells
(NSCs) to internal and external (environmental) stimuli.1–3
Thus, neurogenesis is believed to be a promising therapeutic
target for cell replacement strategies in both brain injury and
neurodegenerative diseases.4–7 However, translational re-
search to reproduce these findings in humans has largely
been prevented by the lack of an adequate method to study
neurogenesis in vivo. Whereas post mortem bromodeoxyur-
idine (BrdU) incorporation studies in cancer patients point to
the existence of some postnatal neurogenesis in the brain,8,9 a
tool for studying the physiological regulation of human
neurogenesis is still unavailable. In 2007, a study by Man-
ganas and colleagues proposed that not only NSCs possess a
cell type-specific peak at 1.28 ppm in proton magnetic reso-
nance spectroscopy (1H-MRS), but also that this peak is
suited to study physiological and pathological regulation of
neurogenesis in both animals and humans in vivo.10 Since
this publication offered the so far missing link for transla-
tional research, it received a high level of attention, but at the
same time it raised several concerns on both the methodo-
logical level and the biological significance. On the one hand,
it was questioned whether the singular value decomposition
(SVD) spectral analysis used in this study was suitable for
generating reliable data, and, on the other hand, the cell type
specificity of the signal was heavily debated.11–14
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The proposed NSC-specific proton magnetic resonance
spectroscopy (1H-MRS) peak has long been known as a
signal derived from methylene groups in fatty acyl residues
in mobile lipids, most likely located in intracellular lipid
bodies.15–17 More importantly, there is substantial informa-
tion available on the correlation of these intracellular lipid
bodies and their associated 1H-MRS signal to different bio-
logical phenomena, particularly apoptosis.16,18 It is unclear
from the above-mentioned study by Manganas and co-
workers how the proposed NSC-specific signal at 1.28 ppm is
related to the already known biological significance of
methylene group–derived lipid resonances and whether it
can be distinguished from these signals at all. Indeed, a re-
cently published study rather put the cell specificity of this
signal and its potential distinction from methylene group–
derived resonances in doubt.14
Together, it remains enigmatic whether there is a speci-
ficity of the signal at 1.28 ppm in 1H-MRS for NSCs or
whether this signal or adjacent/overlapping signals are re-
lated to various forms of cell degradation or death inde-
pendent of the cell type. Thus, we studied the relevance of
this peak using high-field 1H-MRS in a wide set of undif-
ferentiated and maturely differentiated cell populations of all
germinal sheets and quantitatively correlated it with the rate
of apoptosis or necrosis as different forms of cell death.
Materials and Methods
Cell culture
Cells were cultured according to established protocols for
the respective cell type. Fetal cortical NSCs were isolated
from embryonic C57/BL6 mouse brain at embryonic day 14
(E14) and cultured in neurospheres as described in Milosevic
et al.19 These neurosphere cultures were highly enriched
NSC cultures with 91.4! 9.2% of nestinþ NSCs (n¼ 5). The
protocol used for mixed primary neural cultures containing
both glial and neuronal cells was reported in Freudenberg
et al.20 Pure astrocytic cultures were prepared according to
Song et al.,21 embryonic stem (ES) cells and ES-cell derived
NSCs according to Kawasaki et al.,22 and induced pluripo-
tent stem (iPS) cell–derived NSCs and embryonic fibroblasts
as described in Kim et al.23 MN9D cells were grown ac-
cording to Heller et al.24 and melanoma and glioma cell lines
according to Kirsch et al.25 and Uo et al.,26 respectively. Note
that all cells are of murine origin.
Camptothecin and sodium azide treatment
For induction of apoptosis, camptothecin (Sigma-Aldrich,
Hamburg, Germany) was added to the respective cultures at
5 mM final concentration 18 hr before spectroscopic analysis,
as described in Uo et al.27 Necrosis was induced by sodium
azide (Sigma-Aldrich) 3 hr before analysis at final concen-
trations of 46, 115, and 230mM according to the specifica-
tions described in Lizard et al.28
Cell preparation for spectroscopic analysis
Cells were converted into a single-cell suspension by
treatment with 0.05% trypsin-EDTA (Invitrogen, Karlsruhe,
Germany) for 10min at 378C, followed by a 10-min treatment
with a mixture of 40mg of DNase, 150mg of trypsin inhib-
itor, and 1.81 g of MgSO4 (all from Sigma-Aldrich) and
subsequent trituration with fire-polished glass pipettes. Cells
were then washed twice with phosphate-buffered saline
(PBS) and adjusted to a concentration of 10$106 cells/mL. To
500 mL of the cell preparation, 50mL of trimethylsilylpropio-
nate (TMP) in pure deuterium oxide (D2O) was added as a
frequency lock and internal standard (both from Sigma-
Aldrich). Cell suspensions were transferred to nuclear mag-
netic resonance (NMR) sample tubes (VWR International,
Darmstadt, Germany) and kept on ice until 1H-MRS analysis.
NMR acquisition
One-dimensional 1H-NMR spectra of the aqueous sus-
pensions of cells (0.55mL, pH 7.25) containing 10% D2O as a
field frequency lock were measured using a 600-MHz Bruker
Avance NMR spectrometer (Bruker Biospin, Rheinstetten,
Germany). Spectral analysis was conducted using XWinNMR,
v. 3.5. In all experiments, the temperature was maintained at
358C and pH at 7.25. The spectra were acquired as free in-
duction decay (FID, 32,768 points in a spectral width of
8,389.3Hz, readout time of 1.95 sec, repetition time of 2 sec and
128 averages). To minimize the large water peak, the water
signal was presaturated with a low-power radiofrequency
pulse.9 Exposure of cell cultures to these MRS conditions did
not influence their apoptosis rates (data not shown).
Data processing/spectral analysis
Processing of measured data was performed using the
TopSpin software (BRUKER BioSpin, v. 1.3). Before Fourier
transformation, FIDs were processed with a line-broadening
function of 1.0Hz. Then 1H-NMR spectra were phase and
baseline corrected for distortions and referenced to tri-
methylsilylproprionate (TSP; chemical shift 0.00 ppm). No
significant broadening of the TSP resonance was detected in
the presence of the investigated cells. After peak picking and
integration, a deconvolution (mixed line shapes of Lor-
entzian and Gauss) was performed, followed by the nor-
malization of the individual integral values using the TSP
peak (defined constant concentration).
Measuring of apoptosis, cell cycle distribution,
and necrosis
Immediately after 1H-MRS analysis, the cell samples were
tested for the respective level of apoptosis and necrosis.
Determination of apoptotic cell fraction and cell cycle dis-
tribution was carried as described in Nicoletti et al.29 and
Glick et al.30 Briefly, 1$105 of the total cells measured were
washed once with PBS and then resuspended in 300mL hy-
potonic lysis buffer (0.1% sodium citrate, 0.1% Triton X-100,
50 mg/mL propidium iodide [Invitrogen, Karlsruhe, Ger-
many]). After an incubation period of 30min on ice and in
the dark, cells were directly analyzed using fluorescence-
activated cell sorting (FACS; LSRII FACS analyzer, Becton &
Dickinson, Heidelberg, Germany). Testing for necrosis was
performed using the LIVE/DEAD! Fixable Dead Cell Stain
Kit according to the manufacturer’s specifications (L34955,
Invitrogen, Karlsruhe, Germany).
Statistical analysis
Statistics were calculated using SPSS software Version 16.0
(SPSS, Chicago, IL). Significant differences between two or
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more groups were determined using the Student two-sided
unpaired t-test or analysis of variance (ANOVA), respec-
tively. A p value< 0.05 was accepted as significant. The
Pearson correlation coefficient or multiple linear regression
modeling using different exclusion criteria was used to test
correlation and predictive value for the peak at 1.28 ppm as
the dependent variable. Individual values were used for
statistical analysis, with the exception of cell diameter. Cell
diameter showed little variance between different samples of
the same cell type. Therefore, the mean cell diameter was
used in those samples where individual values had not been
collected.
Results
1.28-ppm peak expression in high-field 1H-MRS
spectra of living cells during neural
developmental specification
Figure 1 shows a high-field 1H-MRS spectrum of a living
murine fetal (E14) neurosphere culture of highly purified
NSCs as a representative spectrum from the various stem cell
populations investigated in this study. The peak of TSP at
0.00 ppm was used as a frequency lock and internal standard
for quantitative comparisons between the different samples.
Peaks of metabolites characteristic for quickly dividing cell
populations, such as choline, were detected in addition to
different amino acids (succinate, glutamate, alanine, valine)
and lactate as the end product of anaerobic glycolysis. Other
studies investigating the chemical footprint of different cell
types typically do not work with intact cells, but rather with
cell constituents after cell degradation and lyophilization.31
This approach allows for a much more detailed study of the
chemical constituents than is possible by the directly ex vivo
spectra recorded in this study. However, it also prevents the
analysis of signal changes related to biological activity or the
physicochemical environment of different metabolites in in-
tact cells.
We studied 1.28-ppm peak intensities over all major steps
of neural development in vitro from pluripotent embryonic
stem (ES) cells over NSCs of various origins (ES cell– and
induced pluripotential stem [iPS] cell–derived NSCs, pri-
mary fetal cortical NSCs) to mature neural cell cultures, in-
cluding maturely differentiated NSCs, primary mixed
cortical cultures (consisting of glial and neuronal cell types),
and primary astrocytes. The peak of interest at 1.28 ppm
could readily be detected in the spectra of all mentioned cell
populations without any systematic change of integral peak
intensity with respect to the developmental stage of the cell
population (Figs. 2A,B). Moreover, glioma cells and the
MN9D cell line as well as nonneural cell types, such as em-
bryonic fibroblasts or melanoma cells, also expressed the
1.28-ppm peak clearly above the background noise level
(Figs. 2A,B). Because the peak at 1.28 ppm as a lipid-derived
signal could be related to differences in the net lipid content
of cells of different sizes, we compared peak intensities and
cell diameters, not finding any correlation between these two
parameters (Fig. 2C; r¼ 0.14, p¼ 0.54, Pearson correlation
coefficient). Besides this lack of correlation with cell size,
qualitative and quantitative comparisons of 1.28-ppm peak
intensities with cell type neither revealed any specificity of
the peak for undifferentiated stem cells nor for neural stem
cells and their progeny (Fig. 2).
Effects of apoptosis and cell cycle distribution on peak
intensity at 1.28 ppm in various cell systems
In contrast to the unspecific nature of the 1.28-ppm peak
with respect to the cell type and its developmental stage,
comparison of the integral signal intensity with apoptosis
showed a clear correlation of peak intensity with spontane-
ous apoptosis rate. In untreated cell cultures, cell types with
a low integral intensity of the peak at 1.28 ppm, such as as-
trocytic or primary cortical cultures, were without exception
those that had low levels of spontaneous apoptosis (Fig.
2A,B). Thus, we quantitatively measured the correlation be-
tween peak intensities at 1.28 ppm and apoptotic cell death
in various cell types. Apoptosis was induced by an 18-hr
treatment with camptothecin, a frequently used potent in-
ductor of apoptosis in a variety of cell types.32 The level of
apoptosis was measured by the intensity of the sub-G1 peak
FIG. 1. Representative high-field proton magnetic reso-
nance spectroscopy (1H-MRS) spectrum of a neurosphere
culture of embryonic neural stem cells (NSCs) derived from
embryonic cortical tissue dated embryonic day 14 (E14). The
lower trace represents the original spectrum whereas the
upper trace shows its computed fit, which was used for
quantitative analysis. Besides typical metabolites, such as
choline, succinate, glutamate, alanine, lactate, and valine,
lipid-derived signals are detected both around 1.28 ppm
(arrowhead) and between 0.88 and 0.94 ppm (two arrow-
heads), displaying the typical broader shape of lipid-derived
peaks. Whereas the peak at 1.28 ppm has been described to
originate from mobile methylene (CH2) groups in mem-
brane-associated lipids organized in so called internal lipid
bodies, the peaks between 0.88 and 0.94 ppm have been re-
lated to methyl (CH3) groups in membrane-associated lipids.
The intensity of both signals is known to change in a variety
of biological processes, such as apoptosis, cell degeneration
in general, or inflammation. The peak at 0.00 ppm is gener-
ated by trimethylsilylpropionate (TSP) and used as an in-
ternal standard.
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in propidium iodide (PI)-FACS analysis of degraded hypo-
diploid nuclei as a common final path of different forms of
apoptosis (Fig. 3A).29 Treatment with camptothecin resulted
in a highly significant increase of the apoptotic culture rate
only in some cultures (Figs. 3 and 4A–C), whereas other cell
types were resistant to the treatment and showed no signif-
icant increase in apoptosis (Figs. 3 and 4D–F). Consistent
with the observation in untreated cells, significant increase of
1.28-ppm peak intensities was exclusively observed in cell
cultures with significant induction of apoptosis (Fig. 4).
We then calculated statistical correlations between all cell
types (treated with camptothecin or untreated) and the
measured apoptotic rate. Multiple linear regression analysis
using different exclusion criteria revealed that the peak in-
tensity at 1.28 ppm was significantly determined by the level
of apoptosis only (Fig. 5A; r2¼ 0.6, b¼ 0.78, p< 0.001), and
FIG. 2. Intensity of the resonance at 1.28 ppm in proton magnetic resonance spectroscopy (1H-MRS) in living cell cultures is
not correlated with cell type or neuro-developmental stage. (A) Mean spectra of all untreated samples of a cell type are
displayed ordered according to the respective developmental stage, going from undifferentiated embryonic stem (ES) cells
over neural stem cells (NSCs) of different origin (derived from ES cells, fetal cortical brain cultures, or from induced
pluripotent stem [iPS] cells) to differentiated neural cell types (primary cortical cultures, astrocytes, or MN9D dopaminergic
cell line). In the upper part of A, the mean spectra of two different tumor cells (glioma and melanoma), as well as of
embryonic fibroblasts as an example of a nonneural cell type, are displayed. The area are under the curve of the peaks at
1.28 ppm is marked in grey; the percentage of apoptotic cells is shown as percentage in squared brackets. No correlation
between the intensity of the resonance at 1.28 ppm and cell type or neuro-developmental cell stage becomes apparent. Only
some NSC cultures clearly express the peak, in addition to an expression of the peak by both differentiated neuronal cultures
(MN9D) and cells of nonneural origin (embryonic fibroblasts). (B) Intensities of the resonance at 1.28 ppm of all cell types
ordered according to their neuro-developmental stage, going from pluripotent embryonic stem cells to primary cortical
cultures consisting mostly of differentiated mature brain cells. Separated by a dashed line, the resonances of tumor cells and
nonneuronal cells are displayed on the right. Values for the individual cell samples tested are shown as small grey squares,
whereas mean values for a cell type are displayed as larger white squares (including the standard deviation). As in A, no
change of intensity of the 1.28-ppm resonance in relation to the developmental stage level of the cell type tested becomes
apparent. (C) Correlation of resonance intensities at 1.28 ppm with cell diameters of all cell samples is displayed. No
significant correlation could be detected between these parameters (parameters shown are from the Pearson correlation).
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not by any cell type (Fig. 5B; p> 0.05 for all), cell diameter
(Fig. 5C; p¼ 0.45) or treatment with camptothecin (not
shown; p¼ 0.23). Previous reports suggested that the ratio
between methylene-derived signals around 1.28 ppm and
methyl groups–derived signals around 0.9 ppm provides a
reliable marker for apoptosis.18 The results of linear regression
modeling of the methylene/methyl (CH2/CH3) ratio resulted
in similar results for the predictive value of apoptosis as in the
respective analysis comparing 1.28-ppm peak integral inten-
sities only with the level of apoptosis (Fig. 5D). However,
using the CH2/CH3 ratio, an accompanying predictive value
for the CH2/CH3 ratio could be found in addition to apo-
ptosis for ES cell type, but not for all other cell types, cell
diameter, or treatment with camptothecin (results of multiple
regression analysis: r2¼ 0.75; apoptosis, b¼ 0.70, p< 0.001; ES
cells, b¼ 0.44, p¼ 0.03; all other variables p> 0.05).
Despite the close interaction between apoptosis and the
cell cycle and the observation of a significant negative cor-
relation between the proportion of cells in apoptosis and in
G0/G1 phase in this study (r¼% 0.446, p¼ 0.001, Pearson
correlation), no correlation could be found between the peak
intensity at 1.28 ppm and different phases of the cell cycle as
distinguished by FACS-based cell cycle analysis (Fig. 5G–I; p
values for all cell cycle phases >0.05, Pearson correlation).
However, the CH2/CH3 ratio as an alternative MRS marker
for apoptosis showed a slight negative correlation with the
proportion of cells in G0/G1 phase (r¼%0.401, p¼ 0.04,
Pearson correlation).
FIG. 3. Effects of apoptosis on 1.28-ppm peak intensity in proton magnetic resonance spectroscopy (1H-MRS). (A) Ex-
pression of the sub-G1 peak as a measure of apoptosis either spontaneously or after apoptotic treatment with camptothecin in
two representative cultures of embryonic neural stem cells (NSCs). (B) 1H-MRS spectra of different cultures of embryonic
NSCs are displayed as a function of their apoptotic rate. The differences in apoptosis either were spontaneous, or induced by
an 18-hr treatment with camptothecin (5 mM final concentration). A constant increase in the integral of the peak at 1.28 ppm
was detected with increasing fractions of apoptotic cells in the cultures. (C) Mean spectra of various cell types were generated
for the untreated samples, as well as for the samples treated with the apoptosis-inducing agent camptothecin and ordered
according to their apoptotic rate. Again, samples that had a low spontaneous rate of apoptosis or were resistant to the
treatment with camptothecin (astrocytes) displayed integral intensities at 1.28 ppm at the detection limit, whereas cell types
with a high spontaneous or chemically induced apopototic rate also had high intensities of the integral of the peak at
1.28 ppm. ES cell, Embryonic stem cell; iPS cell, induced pluripotential cell.
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Prediction by the independent variables in this study in a
linear regression model was possible for the peak at
1.28 ppm only and not for two other metabolites detected by
1H-MRS, namely lactate and choline, showing no significant
prediction of these metabolites by apoptosis rate, cell type,
diameter or treatment (Figs. 5E,F; multiple regression anal-
ysis: r2¼ 0.20, p¼ 0.06 and %0.09, p¼ 0.78).
Effects of necrosis on peak intensity at 1.28 ppm
in fetal cortical NSCs
Methylene group–derived signals in the spectral region at
1.28 ppm had also been suggested to be related to necrosis as
an uncontrolled form of cell death.16 Therefore, we compared
the intensities of the peak at 1.28 ppm in fetal cortical NSC
cultures with the level of necrosis (Fig. 6). Necrosis was in-
duced with sodium azide, which deprives cells of their en-
ergy supply by blocking cytochrome c oxidase.29 Although
this treatment resulted in a nearly complete induction of
necrosis (93.5! 2.2% in the samples treated with the highest
concentration of 230mM (n¼ 4; Fig. 6A,C), no increase in the
1.28 peak intensity was detected (Fig. 6B,C). Accordingly,
there was no correlation between the peak intensity at
1.28 ppm and the level of necrosis in this cell type (Fig. 6D;
r¼ 0.05, p¼ 0.86, Pearson correlation coefficient).
Discussion
We aimed at understanding the biological relevance of the
1H-MRS signal at 1.28 ppm in living cells, which was pro-
posed as a NSC-specific signal and how this signal relates to
the known biological significance of lipid-derived signals
located precisely in this spectroscopic region.10 Our results
did not reveal any correlation of the peak at 1.28 ppm with
NSCs or any other cell type tested, but showed a strong
correlation of the peak with apoptotic cell death. We also
tested the peak intensity at different developmental stages
from pluripotent ES or iPS cells over NSCs to differentiated
FIG. 4. Quantitative comparison of intensities of the integral of the peak at 1.28 ppm and apoptotic rates. In the upper part
of the figure (A–C), cell cultures are displayed where the treatment with camptothecin lead to a significant increase in
apoptosis, accompanied by a corresponding significant increase in integral intensities at 1.28 ppm. (Grey bars) Mean integral
intensities at 1.28 ppm and refer to the y axis on the left side; (white bars) mean level of apoptosis of the treated and untreated
cultures and refer to the y axis on the right side. Whereas the treatment with camptothecin of embryonic stem (ES) cells (A),
embryonic neural stem cells (NSCs) (B), and glioma cells (C) resulted in a significant induction of apoptosis ( p< 0.01 for all)
and was accompanied by a significant induction of integral intensities at 1.28 ppm, the treatment of primary cortical cultures
(D), astrocytes (E), and MN9D as a dopaminergic neural cell line (F), either had no effect on the apopotic rate, or to a
significance level of p< 0.05 only, accompanied by no increase in integral intensities at 1.28 ppm. (*) Significant different
results with p< 0.05; (**)significant results with p< 0.01.
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neuronal cells types, but could not find any specificity for
any of these developmental stages. Multiple regression
analysis displayed a significant predictive value of the peak
intensity for apoptosis only, but not for necrosis, cell size, or
cell type. Our data do not support the 1.28-ppm peak in 1H-
MRS as a direct biomarker for NSCs, but its specificity for
apoptosis as a major selection process during neurogenesis
proposes it as an indirect marker of neurogenesis in vivo.
The results of our study are in line with one previous
study on the impact of apoptosis on the peak intensity at
1.28 ppm in NSCs.14 The authors showed that apoptosis in-
duction by menadione increased the peak intensity in all
tested cell types and that it was not present in the absence of
apoptosis, but they did not measure the actual apoptosis rate
in their cultures and thus were not able to correlate the 1.28-
ppm peak intensity with the rate of apoptosis. However,
quantification of the apoptosis rate is of great importance
because there are large differences in both the spontaneous
apoptosis rate and the responsiveness to toxic apoptosis in-
duction between various cell lines (Fig. 4).32 The mechanisms
FIG. 5. Multiple linear regression analysis of integral intensities at 1.28 ppm and various cell parameters. In multiple
regression analysis, a highly significant predictive value for integral intensities at 1.28 ppm was found for level of apoptosis
(A). In contrast, no significant predictive values could be detected for cell type (B), cell diameter (C), or treatment with
camptothecin (not shown). (D) A positive predictive value for the ratio of integral peak intensities of methylene (CH2) groups
located at 1.28ppm and methyl (CH3) groups located between 0.8 and 0.94ppm was also detected. No significant predictive
value could be found in the same linear multiple regression model for two other metabolites typically detected by proton
magnetic resonance spectroscopy (1H-MRS), lactate (E), or choline (F). (G–I) In addition, no significant correlation existed
between integral peak intensities at 1.28ppm and different cell cycle phases as measured by fluorescence-activated cell sorting
[FACS]). The Pearson correlation coefficients for the respective variables are displayed In the upper right part of each graph.
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leading to the differences in apoptosis rates and sensitivity to
apoptotic stressors remain unknown, but are probably at
least in part cell-intrinsic processes. Additionally, the high
variance in apoptosis rates might also be induced by the cell
preparation needed for MRS measurements, whereas MRS
itself does not induce apoptosis (see Materials and Methods
for details). Our study extended markedly the previous
knowledge by measuring peak intensities of a very wide
range of cells at very different apoptotic levels (quantified by
PI-FACS) and analysis by a linear multiple regression model,
which clearly demonstrated that the 1.28-ppm signal is
specifically correlated with the level of apoptosis, but not
with necrosis, cell size, or cell type.
The discrepancies between the two recent studies and the
in vitro studies reported by Manganas and co-workers de-
scribing the 1.28-ppm peak as highly enriched and thus
specific for NSCs and other neuroectodermal progenitor
populations10 could be related to different rates of apoptosis
in the cultures used. We prepared our NSC cultures under
close adherence to the protocol provided byManganas et al.10
FIG. 6. Effects of necrotic cell death on integral intensities at 1.28 ppm in proton magnetic resonance spectroscopy (1H-
MRS). (A) Representative examples of an untreated and a treated culture of embryonic neural stem cells (NSCs). Necrosis was
induced using sodium azide. The increase in cell fluorescence due to the permeabilization of the necrotic cell membrane was
measured by fluorescence-activated cell sorting (FACS) analysis. (B) 1H-MRS spectra of various cultures of embryonic NSCs
are displayed as a function of their necrotic rate, either spontaneous, or due to exposure to sodium azide. (C) Integral
intensities at 1.28 ppm of embryonic NSCs with different levels of necrosis are displayed by the grey bars, referenced to the y
axis on the left side of the graph. Necrosis was induced by increasing concentrations of sodium azide, as indicated. The
resulting level of necrosis is displayed by the recessed white bars with reference to the y axis on the right side of the graph. (*)
Significant differences with p< 0.05. (D) Correlation of the level of necrosis in embryonic NSCs with integral intensities at
1.28 ppm. In contrast to apoptosis, no significant correlation between the two parameters could be found (Pearson correlation
coefficient). NaN3, Sodium azide.
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and measured considerable levels of at least 9% of sponta-
neous apoptosis in these cultures, accompanied by a corre-
sponding signal at 1.28 ppm. Unfortunately, Manganas and
co-workers did not measure apoptosis or cell death in their
study. Consistently, cell types that were used as negative
controls by Manganas and colleagues, such as astrocytes or
differentiated neural cell cultures, have a known resistance to
spontaneous and induced apoptosis and also displayed a
low intensity or absence of the 1.28-ppm peak in our study.32
The specificity for apoptosis of the peak at 1.28 ppm is fur-
ther supported by the finding that even NSC cultures with
very low levels of cell death do not display the peak at
1.28 ppm.14
A recent publication focusing on methodological aspects
of spectrum analysis did not completely rule out that in the
spectral region of interest around 1.28 ppm there are both a
NSC-specific peak at low signal intensity and already known
peaks derived from mobile methylene groups.33 However,
evidence for the existence of two distinct signals in the same
spectral region was neither found by the cited experimental
study on cell-specificity of the signal nor by our results.14
Apoptosis is a proliferation-related event, because cells
have to be in the active phases of the cell cycle to undergo
programmed cell death.34–36 Additional analysis revealed no
correlation between the intensity of the peak at 1.28 ppm and
other phases of the cell cycle, whereas for the CH2/CH3
ratio a mild negative correlation could be found with the
proportion of the cells in G0/G1 phase. However, this cor-
relation was much weaker than the correlation between
CH2/CH3 and apoptosis (r¼%0.401 versus r¼ 0.784, Pear-
son correlation). These data further support that the peak
at 1.28 ppm is related primarily to apoptosis, because apo-
ptotic cells have been found in this and other studies to re-
cruit mainly from the cell population in G0/G1 phase, so that
the mild negative correlation can be viewed as an indirect
effect.37
Cultures of quickly proliferating cell populations, such as
tumor or stem cells, are particularly prone to induction of
apoptosis, which can be favored even by scarcity of nutrition
or contact inhibition characteristic for quickly proliferating
cultures. Thus, there is no need for a second, cell-specific
signal in this spectral region to explain the differences in
peak intensity observed in different cultures. In our study,
NSCs were the most sensitive to spontaneous and toxic in-
duction of apoptosis, and this suffices to explain the high
intensity of the peak in NSC cultures. The former study by
Ramm and colleagues and our study cannot fully rule out
the existence of a NSC-specific signal in the same spectral
region subjacent to the apoptosis-related 1.28-ppm peak.14
This seems however very unlikely, because the peak was not
detectable in NSC cultures with very low levels of cell
death.14
Our results are well in line with a considerable number of
experimental and clinical studies on the origin and biological
significance of the spectroscopic signal from lipid-derived
methylene groups. The signal has been linked to an increased
mobility of methylene groups in membrane lipids as the
result of the conformation of so called internal lipid bodies, a
process strongly related to apoptotic cell death, but also to
other rather cell type–independent biological processes such
as inflammation, malignant proliferation, or necrosis.16 The
link of the signal has been best established for apoptosis and
has found entry into clinical diagnostic procedures, such as
the evaluation of tumor regression or type.38–40 The two tu-
mor cell types studied in the present report, mouse mela-
noma and glioma cells, were also prone to the induction of
apoptosis and depicted a concomitant high peak intensity.
Manganas and co-workers additionally used two models
to claim the usefulness of the 1.28-ppm signal for studying
NSC behavior in vivo. First, NSCs were transplanted into rat
brains and subsequently detected by the peak at 1.28 ppm.
However, this paradigm seems to be unsuitable for distin-
guishing between the in vivo detection of a cell-specific signal
and the detection of an apoptosis-derived signal in the same
spectral region, because it has been shown that the majority
of transplanted cells do not survive the procedure of trans-
plantation (up to 96%) and undergo apoptosis or necrosis.41
The second model used was electroconvulsive shock treat-
ment as a potent inductor of neurogenesis. This paradigm is
not only a potent inductor of NSCs proliferation and their
nonfunctional differentiation, but also of apoptotic cell death
of the majority of newborn cells,42,43 thus it is not able to
provide a clear distinction between a NSC-specific and an
apoptosis-specific MRS signal. It is noted that these limita-
tions do not necessarily disable the method for studying
neurogenesis in vivo, because estimating the rate of apoptosis
within the neurogenic niche might be an indirect measure of
stem cell turnover or homeostasis as supported by the results
of Manganas and co-workers.10
Together, our study provides evidence that the peak at
1.28 ppm in 1H-MRS spectra is a specific marker for apo-
ptosis, and its intensity neither correlates with a distinct cell
type, such as NSCs, nor with other cellular states, such as
necrosis or cell cycle phase distribution. Because the apo-
ptotic cell death is a biological process closely related to stem
cell functioning and homeostasis, our results do not exclude
a relevance of this signal in studying NSC biology in vivo as
reported by Manganas and colleagues.10 Because in vivo 1H-
MRS provides spatially resolved spectral information, it
could be used to obtain indirect information about the reg-
ulation and homeostasis of the NSC pool within neurogenic
niches by studying the local apoptosis rate.
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